<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01637545</url>
  </required_header>
  <id_info>
    <org_study_id>B-1107-131-007</org_study_id>
    <secondary_id>L-2011-329-1</secondary_id>
    <nct_id>NCT01637545</nct_id>
  </id_info>
  <brief_title>Evaluation of Safety and Efficacy of Nasea(R)/Ramosetron Inj. in Patients Undergoing Facial Bone Fracture Operations</brief_title>
  <official_title>Phase 4 Study of Nasea(R)/Ramosetron Inj.as Anti-emetics in the Patients Undergoing Facial Bone Fracture Operations</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Postoperative nausea and vomiting (PONV) is one of the most common and distressing
      complications after anaesthesia and surgery, and may lead to serious postoperative
      complications This prospective, randomized study designed to evaluate the best injection time
      to get the prophylactic anti-emetic efficacy of ramosetron, a newly developed 5-HT(3)
      antagonist in patients undergoing facial bone surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Participants

             -  100 patients with undergoing facial bone surgery are going to be randomly allocated
                to one of the 3 groups

        2. Randomization

             -  G1(n=33) - Ramosetron 0.3mg i.v. just before the beginning of the surgery

             -  G2(n=33) - Ramosetron 0.3mg i.v. just after the end of the surgery and moving into
                the Recovery room

             -  G3(n=33) - No medication but regular antiemetics i.v. if the patient wants

        3. The primary endpoint

             -  the incidence of nausea and vomiting for 24 h after surgery at 0-6h, 6-12 h and
                12-24 h

        4. The secondary endpoints

             -  the severity of nausea, need for rescue medication

             -  patient satisfaction with efficacy
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Principal Investigator is away on business
  </why_stopped>
  <start_date>December 2011</start_date>
  <completion_date type="Actual">February 2015</completion_date>
  <primary_completion_date type="Actual">February 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>incidence and severity of nausea and vomiting</measure>
    <time_frame>for 24 h after surgery at 0-6h, 6-12 h and 12-24 h</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>patient satisfaction with the effect</measure>
    <time_frame>at 24 h after surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">49</enrollment>
  <condition>Facial Bones Fracture</condition>
  <arm_group>
    <arm_group_label>Preop. ramosetron 0.3mg i.v.</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>G1 - Ramosetron 0.3mg i.v. just before the beginning of the surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Postop. ramosetron 0.3mg i.v.</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>G2 - Ramosetron 0.3mg i.v. just after the end of the surgery and moving into the Recovery room</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Ramosetron</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>G3 - No medication but regular antiemetics injection if the patient wants</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ramosetron</intervention_name>
    <description>G1 - Ramosetron 0.3mg i.v. just before the beginning of the surgery G2 - Ramosetron 0.3mg i.v. just after the end of the surgery and moving into the Recovery room
G3 - No medication but regular antiemetics injection if the patient want</description>
    <arm_group_label>Preop. ramosetron 0.3mg i.v.</arm_group_label>
    <arm_group_label>Postop. ramosetron 0.3mg i.v.</arm_group_label>
    <arm_group_label>No Ramosetron</arm_group_label>
    <other_name>NaseaÂ®</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient who sign informed consent form for the study

          -  patient who are considered as surgical candidates with facial bones fracture

        Exclusion Criteria:

          -  Patient who have had nausea/vomiting episodes
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chanyeong Heo, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Bundang Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam-si</city>
        <state>Gyeonggi-do</state>
        <zip>463-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 8, 2012</study_first_submitted>
  <study_first_submitted_qc>July 10, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 11, 2012</study_first_posted>
  <last_update_submitted>May 7, 2015</last_update_submitted>
  <last_update_submitted_qc>May 7, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 8, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Chan-Yeong Heo</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>facial bones</keyword>
  <keyword>Post operative nasea vomiting</keyword>
  <keyword>fractures</keyword>
  <keyword>reduction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Facies</mesh_term>
    <mesh_term>Skull Fractures</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ramosetron</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

